(Q74238427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

K Kaku

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Urae

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Irie

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

Diabetes Research and Clinical Practice

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

119-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Insulin delivery devices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Continuous subcutaneous insulin infusion: Comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Absorption kinetics and biologic effects of subcutaneously injected insulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Action profile of the rapid acting insulin analogue: human insulin B28Asp

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900151-0

7 January 2021

10.1016/S0168-8227(00)00151-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10963823%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference